Skip to main content
A

AUDEARA LIMITED — Investor Relations & Filings

Ticker · AUA ISIN · AU0000145807 LEI · 984500D8CD90E0BWE175 ASX Manufacturing
Filings indexed 270 across all filing types
Latest filing 2026-04-22 Board/Management Inform…
Country AU Australia
Listing ASX AUA

About AUDEARA LIMITED

https://audeara.com

Audeara Limited specializes in the development of personalized audio solutions designed to enhance hearing health and sound clarity. The company’s primary offering consists of headphones integrated with proprietary software that performs a clinical-grade hearing test. This assessment generates a unique hearing profile, allowing the hardware to adjust sound frequencies in real-time to meet the specific auditory requirements of the user. By tailoring sound to individual hearing profiles, the technology aims to provide high-fidelity audio while minimizing the risk of further hearing degradation. These solutions are frequently implemented in clinical settings and by individuals seeking assistive listening devices that bridge the gap between traditional consumer electronics and medical hearing aids. The focus remains on delivering customized auditory experiences through innovative signal processing and user-centric design.

Recent filings

Filing Released Lang Actions
Transition of Chief Technology Officer 2 pages 273.7KB
Board/Management Information Classification · 1% confidence The document is an ASX announcement dated 23 April 2026 describing the resignation of the Co-founder and Chief Technology Officer and the planned transition. It details changes in senior management (the CTO stepping down), includes quotes from the CEO and the departing executive, and is authorised by the Board. This fits the definition of a Board/Management Information announcement regarding changes in the company’s senior management.
2026-04-22 English
Audeara Secures Exclusive Deal with Shokz Health Global 4 pages 1.2MB
Regulatory Filings Classification · 1% confidence The document is an ASX market announcement describing a commercial distribution agreement with Shokz Health Global. It is not an earnings release, proxy, dividend notice, M&A bid, share issue, or management change. There is no attached detailed report or financial statements. It’s a general regulatory announcement about a partnership, which falls under the fallback category Regulatory Filings (RNS).
2026-04-15 English
Q3 FY26 Quarterly Activities Report & Appendix 4C 11 pages 660.3KB
Regulatory Filings
2026-04-13 English
Application for quotation of securities - AUA 6 pages 18.6KB
Regulatory Filings
2026-04-13 English
Auracast platform expansion underway with Clinico Inc 4 pages 382.2KB
Regulatory Filings
2026-03-08 English
Appendix 4D & Half-Year Financial Report to 31 December 2025 25 pages 1.3MB
Regulatory Filings
2026-02-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.